Open access
Aug 2026
A prognostic lncRNA signature associated with ribonucleotide reductase predicts overall survival and immune landscape in hepatocellular carcinoma
The RR‐related lncRNA signature integrates prognostic, immune, and metabolic features in HCC and may serve as a promising tool for risk stratification and personalized treatment guidance, while the identified lncRNAs provide potential candidates for further mechanistic investigation.
Kepu Zheng, Haitao Jiang, Yanghui Wen et al.
· Frontiers in Cell and Develo... · 0 citations